Vanguard Group Inc Century Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,377,494 shares of IPSC stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,377,494

Previous 2,381,707 0.18%

Holding current value

$1.31 Million

Previous $2.41 Million 52.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$0.48 - $1.11 $2,022 - $4,676	-4,213 Reduced 0.18%	2,377,494 $1.14 Million
Q4 2024 Feb 11, 2025	SELL	$1.0 - $1.72 $93,508 - $160,833	-93,508 Reduced 3.78%	2,381,707 $2.41 Million
Q3 2024 Nov 13, 2024	BUY	$1.44 - $3.29 $1.07 Million - $2.44 Million	743,082 Added 42.9%	2,475,215 $4.23 Million
Q2 2024 Aug 13, 2024	BUY	$2.46 - $4.05 $1.46 Million - $2.4 Million	593,480 Added 52.12%	1,732,133 $4.42 Million
Q1 2024 May 10, 2024	BUY	$3.19 - $5.32 $44,660 - $74,480	14,000 Added 1.24%	1,138,653 $4.76 Million
Q4 2023 Feb 14, 2024	BUY	$1.28 - $3.32 $7,018 - $18,203	5,483 Added 0.49%	1,124,653 $3.73 Million
Q3 2023 Nov 14, 2023	SELL	$2.0 - $3.23 $57,110 - $92,232	-28,555 Reduced 2.49%	1,119,170 $2.24 Million
Q2 2023 Aug 14, 2023	BUY	$2.91 - $3.53 $106,668 - $129,395	36,656 Added 3.3%	1,147,725 $3.63 Million
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $114,229 - $171,680	33,597 Added 3.12%	1,111,069 $3.86 Million
Q4 2022 Feb 10, 2023	BUY	$4.84 - $11.58 $42,514 - $101,718	8,784 Added 0.82%	1,077,472 $5.53 Million
Q3 2022 Nov 14, 2022	BUY	$8.57 - $13.1 $1.39 Million - $2.12 Million	161,713 Added 17.83%	1,068,688 $10.6 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $12.43 $694,215 - $1.08 Million	87,213 Added 10.64%	906,975 $7.62 Million
Q1 2022 May 13, 2022	BUY	$11.62 - $15.92 $3.16 Million - $4.33 Million	271,760 Added 49.59%	819,762 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $1.58 Million - $2.68 Million	113,392 Added 26.09%	548,002 $8.69 Million
Q3 2021 Nov 12, 2021	BUY	$20.8 - $31.93 $8.42 Million - $12.9 Million	404,610 Added 1348.7%	434,610 $10.9 Million
Q2 2021 Aug 13, 2021	BUY	$22.45 - $29.34 $673,500 - $880,200	30,000 New	30,000 $880,000

Others Institutions Holding IPSC

# of Institutions

Shares Held

26.9M

Call Options Held

12.1K

Put Options Held

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $32.4M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Century Therapeutics, Inc. Transaction History